Attitudes and Practices of Immune Checkpoint Inhibitors in Chinese Patients With Cancer: A National Cross-Sectional Survey
Immune-checkpoint inhibitors (ICIs) are revolutionizing the field of immuno-oncology. Side effects and tumor microenvironment currently represent the most significant obstacles to using ICIs. In this study, we conducted an extensive cross-sectional survey to investigate the concept and practices reg...
Main Authors: | Luping Zhang, Jun Wang, Bicheng Zhang, Qian Chu, Chunxia Su, Hao Wu, Xiaobing Chen, Baocheng Wang, Yongmei Yin, Bo Zhu, Jianguo Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.583126/full |
Similar Items
-
Management of immune checkpoint inhibitor‐related adverse events: A review of case reports
by: Xiaoyan Si, et al.
Published: (2020-03-01) -
Cardiovascular Immunotoxicity Associated with Immune Checkpoint Inhibitors in Metastatic Melanoma
by: Jean-Matthieu L’Orphelin, et al.
Published: (2023-04-01) -
Rheumatic complications in cancer patients treated with immune checkpoint inhibitors
by: Kyung-Ann Lee, et al.
Published: (2019-11-01) -
Immune-Mediated Adverse Effects of Checkpoint Inhibitors: A Clinical Experience
by: Juřica Jan, et al.
Published: (2022-06-01) -
What is the optimal duration of immune checkpoint inhibitors in malignant tumors?
by: Jiaxin Yin, et al.
Published: (2022-09-01)